+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma

Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma

Molecular Medicine Reports 12(2): 2668-2676

Neuropilin 1 (NRP1), a receptor of vascular endothelial growth factor (VEGF), promotes angiogenesis, tumor growth, tumor invasion and metastasis. However, the function of NRP1 in melanoma progression, as well as the effect of NRP1 expression on the prognosis of patients with melanoma remains unknown. In the present study, NRP1 expression was examined in 460 cases of melanocytic lesions (28 common nevi, 51 dysplastic nevi, 250 primary melanoma and 131 metastatic melanoma) at different stages, using a tissue microarray. The correlation of NRP1 expression with melanoma progression, and its prognostic value in patients with melanoma was examined. In addition, the correlation between matrix metalloproteinase 2 (MMP2) and NRP1 expression in patients with melanoma was analyzed. The results demonstrated that NRP1 expression was significantly increased in primary (56%) and metastatic melanoma (62%), compared with common nevi (11%) and dysplastic nevi (24%). Notably, increased NRP1 expression was correlated with a poorer overall, and disease-specific, 10-year survival (P=0.03 and P=0.002, respectively). Multivariate Cox regression analyses indicated that NRP1 is an independent prognostic marker for melanoma. Furthermore, a significant positive correlation between NRP1 and MMP2 expression in melanoma biopsies was observed, and their concomitant expression was closely correlated with melanoma patient survival, further supporting the hypothesis that the expression of NRP1 is associated with melanoma invasion and metastasis. In conclusion, increased NRP1 expression is associated with disease progression and reduced survival in patients with melanoma, and is a promising prognostic molecular marker for this disease.

(PDF emailed within 0-6 h: $19.90)

Accession: 058096833

Download citation: RISBibTeXText

PMID: 25954957

DOI: 10.3892/mmr.2015.3752

Related references

Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Pigment Cell & Melanoma Research 24(1): 175-186, 2011

Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma. British Journal of Dermatology 171(2): 403-408, 2015

Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma. Journal of Investigative Dermatology 125(3): 526-531, 2005

Prognostic significance of the high molecular weight-melanoma associated antigen in sera of patients with melanoma. Journal of Investigative Dermatology 119(1): 242, July, 2002

Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon. British Journal of Cancer 87(2): 181-186, 2002

Matrix metalloproteinases in human melanoma cell lines and xenografts: Increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. British Journal of Cancer 81(5): 774-782, 1999

Prognostic significance of CD4(+)CD25(+)FOXP3+ regulatory T cells in patients receiving polyvalent allogeneic melanoma cell vaccine for resected stage III and IV melanoma. 2007

Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients. Melanoma Research 14(4): 257-262, 2004

Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. European Journal of Surgical Oncology 27(1): 88-93, 2001

Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. Journal of Clinical Oncology 29(16): 2199-2205, 2011

Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer 47(5): 955-962, 1981

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA). International Journal of Radiation Oncology, Biology, Physics 99(4): 812-816, 2017

Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer 97(7): 1737-1745, 2003

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients. Diagnostic Pathology 10(): 86-86, 2016

The role of nm23 in melanoma progression and its prognostic significance. Polish Journal of Pathology 49(2): 93-96, 1998